What is Enzyme (MLN)?

Deep Dive

1. Purpose and Value Proposition

Enzyme provides infrastructure for decentralized asset management, aiming to replace traditional fund administration with transparent, on-chain operations. It enables users to create vaults that represent investment strategies, which can hold diverse assets (crypto, real-world assets via tokenization). The protocol reduces costs and counterparty risks by automating processes like fee collection and asset tracking. Recent institutional adoption, such as the CV5 Capital partnership (November 2025), highlights its role in tokenizing regulated funds.

2. Technology and Architecture

Built on Ethereum, Enzyme uses smart contracts to enforce rules for fund creation, deposits, and redemptions. Its modular design includes:
- Enzyme Blue: A user-friendly platform for creating no-code vaults, supporting strategies across DeFi protocols.
- Enzyme Onyx: Launched for institutional use, Onyx enables cross-chain strategies and interaction with both decentralized (DeFi) and centralized (CEXs, banks) systems. The Chainlink CRE integration (November 2025) enhanced Onyx’s ability to automate compliance and reporting for traditional assets.

3. Tokenomics and Governance

The MLN token has two primary utilities:
- Fee Payment: Users pay fees in MLN (0.25% of vault assets annually) for using the protocol; these tokens are burned, creating deflationary pressure.
- Governance: MLN holders vote via the Enzyme Council DAO on protocol upgrades and fund allocations (e.g., grants for development). Up to 300,600 new MLN can be minted annually for ecosystem growth, but unspent tokens are burned.

Conclusion

Enzyme is a foundational layer for on-chain asset management, bridging DeFi and traditional finance through its vault infrastructure and institutional-focused products. How will its adoption evolve as tokenized real-world assets gain traction?